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This study examined the eﬀects of needle-free electroacupuncture, at ST36 on postoperative pain following hysterectomy. Based
on a double-blind, sham and diﬀerent intervention controlled clinical experimental design, 47 women were randomly allocated
to four diﬀerent groups. Except for those in the control group (Group 1, n = 13), a course of treatment was given of either
sham (Group 2, n = 12), high-frequency stimulation (Group 3, n = 12), or low-frequency stimulation (Group 4, n = 10). All
groups were assessed during the postoperative period for 24 hours. The Visual Analogue Scale was used to determine the amount
of perceived pain felt by each subject. Diﬀerences were found between the means postoperatively at three, four, eight, 16 and 24
hours. Post hoc comparison tests indicated that Group 4 was signiﬁcantly diﬀerent from Groups 1, 2, and 3 at 24 hours. A one-
way ANOVA analysisfor total patient-controlled analgesia demand and doses indicated signiﬁcantdiﬀerences between the groups
F(3,42) = 3.59,P<. 05.Posthocanalysisconﬁrmedthediﬀerences between Groups 1 (M = 84.54)and4(M = 41.60).Treatment
outcomes of this therapy showed a positive eﬀect for the management of postoperative pain.
1.Introduction
Acupuncture has been used for pain relief for thousands
of years, and more recently has included electroanalgesic
therapies as an alternative to conventional pharmaceutical
pain relievers [1]. The aims of this study were to examine the
eﬀects of needle-free electroacupuncture (EA) analgesia on
subjects recovering from hysterectomies. Silver Spike Point
(SSP) needle-free EA was used in this study as opposed
to traditional acupuncture, where needles are inserted into
acupuncture points. SSP needle-free EA stimulation is
achievedcontinuouslywithcontrolledcurrentandfrequency
ensuring that each subject received the same stimulation and
dosages. Xu et al.’s study in Australia [2]c o n ﬁ r m e dt h es i g -
niﬁcant pain-relieving eﬀects that SSP needle-free EA could
provide. SSP needle-free EA, if eﬀective, would have the
advantage of providing pain control with no opioid-related
side eﬀects, such as nausea, dizziness, or the more serious
respiratory depression, central nervous system depression
including somnolence and conscious disturbance. In this
study, it is anticipated that the eﬀects of SSP needle-free EA
analgesia on subjects recovering from hysterectomies would
be greater than the control groups. The results may help
patients by contributing to the knowledge of pain control
and providing signiﬁcant improvement in treatment.
2.Methodology
2.1. Study Design. Based on a double-blind, sham, and dif-
ferent intervention controlled clinical experimental design.
Hysterectomized patients at the China Medical University
Hospital were invited to be subjects in the study. The study
was approved by the related institutions, and ethics approval
was gained from the Human Research Ethics Committee of
La Trobe University Australia and China Medical University
Hospital Taiwan, before conducting the clinical trial. All
subjects were asked to complete a medical suitability form
for SSP needle-free EA treatment, received an explanation
form, and were asked to sign a consent form. Forty-
nine hysterectomized patients who had all received general
anesthetics of propofol 2mg/kg and atracurium 0.5mg/kg2 Evidence-Based Complementary and Alternative Medicine
Table 1: The proposed four experiment groups and their treatment regimes.
Subject
groups
EA treatment
Preoperative Postoperative
Group 1 PCA NIL (control group) NIL (control group)
Group 2 PCA SSP electrode at sham acupuncture point near to ST36
(no stimulation) for 30 minutes.
SSP electrode at sham acupuncture point near to ST36
(no stimulation) for 30 minutes.
Group 3 PCA SSP electrode at ST36 with continuous wave of 100Hz
electrical stimulation for 30 minutes.
SSP electrode at ST36 with continuous wave of 100Hz
electrical stimulation for 30 minutes.
Group 4 PCA
SSP electrode at ST36 with dense-sparse wave
3Hz/4sec,10Hz/4sec,and20Hz/4secelectrical
stimulationfor 30 minutes.
SSP electrode at ST36 with dense-sparse wave
3Hz/4sec,10Hz/4sec,and20Hz/4secelectrical
stimulationfor 30 minutes.
Table 2: Description of subjects.
N Minimum Maximum Mean SD
Age (years old) 47 14.00 59.00 42.02 8.31
Weight (Kg) 47 40.00 158.00 59.74 17.54
Duration (min) 47 65.00 240.00 127.70 34.56
Anesthesia time
(min)
47 94.00 275.00 166.04 35.95
Valid N 47
for induction (but no narcotics), and sevoﬂurane with 50%
nitrous oxide and oxygen for anesthesia were randomly
allocated to receive one of the four pre- and postoperative
procedures. All subjects were randomly assigned to the four
groups, and the group assignments were kept fully blinded
from the subjects and data collectors.
Neither the subjects nor the research assistant carrying
out the procedures was aware of who was receiving the
therapy. The subjects were treated in silence in the surgery
preparing room before the operation. The chief of the
anesthetic team in the operation theatre marked the point
onthesubjects’legs.Neitherthedoctorperforming theinter-
ventions,thesubjects,northenurse collectingtheresultswas
aware of the diﬀerences between the diﬀerent interventions.
Therefore, there was no disclosure to the subjects in relation
to what interventions they had received.
In this study there were four groups of subjects (Table 1).
To ensure that the groups consisted of randomly assigned
subjects, each subject was assigned to a treatment group
in numbered order, as they became available. A random
number table was used for grouping. Every subject in each
group received patient-controlled analgesia (PCA) (Pain
Management Provider TM, Abbott Laboratories, North
Chicago, IL, USA). The groups diﬀered only in the acupunc-
ture procedure they received. In an attempt to control for
the placebo eﬀect of SSP therapy, one “sham acupuncture”
treatment group was included.
According to Traditional Chinese Medicine (TCM) the-
ory, the acupuncture point Zusanli (ST36) was selected for
this study, as it lies on the stomach meridian that traverses
through the abdominal area surrounding the female repro-
ductive organs.
Table 3: Time of ﬁrst bowel movement (in hours).
Group Number Mean SD
1 13 37.54 2.93
2 12 38.03 2.71
3 12 35.50 2.64
4 10 33.30 2.43
In Groups 2, 3, and 4, subjects received treatment com-
mencing 30 minutes before general anesthesia. Subjects
in Group 2 received no stimulation. Subjects in Group
1 received general anesthesia only. Group 3 received SSP
stimulation at 100Hz, and Group 4 received SSP stimulation
by a mixture of dense-sparse wave at 3Hz, 10Hz, and
20Hz. After surgery, SSP needle-free EA treatment was
administered once only and was initiated once the subject
regained consciousness in the recovery room. The SSP
needle-free EA procedure was provided for 30 minutes,
the 1/f Yuragi waves were used. All subjects in each group
received PCA postoperatively. As the subjects received their
treatment in diﬀerent rooms, conﬁdentiality was strictly
followed,andasaresulttherewasnoopportunityforthemto
communicate with each other. Furthermore, as the subjects
had no prior experience of such treatment they were unable
to identify which treatment they are receiving.
All groups were assessed during the postoperative period
for 24 hours using a Visual Analogue Scale (VAS), and total
amountofPCAdemandandtotalamountofPCAdoseswere
recorded. The time of the ﬁrst PCA demand and the fre-
quency of subsequent demands were noted over the ﬁrst 24-
hour period postoperatively. The total dosage of morphine
used was calculated for each group. A VAS measurement
for pain intensity was administered. The data was collected
over a 24-hour period commencing postoperatively (see
Figure 2).
Before discharge, the subjects were asked to answer ques-
tions pertaining to the occurrence of any side eﬀects from
theSSPneedle-free EA treatment,suchas bruising,dizziness,
and anxiety. The VAS was again used to determine the
intensity of pain.
2.2. Subjects. Subjects with medical conditions such as
hypertension, diabetes, cachexia, cardiac, respiratory, kidney
and nervous system problems, coagulopathy, and otherEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: Flow chart of participants through each stage of the trial.
Table 4: Time of ﬁrst ambulation (in hours).
Group Number Mean SD
1 13 32.50 2.41
2 12 33.75 3.11
3 12 33.13 3.18
4 10 29.90 2.95
bleeding disorders were excluded. Subjects with a history
of opioid use and sensitivity to opioid-related side eﬀects
(e.g., nausea, vomiting) were also excluded. Each subject was
instructed on the operational aspects of the PCA device at
the initial preoperative visit and again in the recovery room.
The use of SSP needle-free EA was also explained to Groups
2, 3, and 4 before the operation.
The real acupuncture point ST36 is on the lower leg,
three units (approximately the patient’s four ﬁngers width)
inferior oftheknee patellar ligament, and approximately one
ﬁngerwidthlateraltotheanteriorcrestofthetibia.Thesham
acupuncture point (on the same level as ST36 but above
the tuberositas tibia) was identiﬁed in all subjects one day
prior to the operation. Subjectsreceived one of four diﬀerent
pre- and postoperative treatment regimes. All subjects
were completely anesthetized throughout the surgery. After
surgery, subjects were transported to postanesthetic recovery
(PAR).
2.3. Measurements. The analgesic dosage levels at which
patients experience pain relief varies greatly as does the
patient’s sensitivity to pain. Using PCA, patients are able
to determine their own analgesic requirements. After one
hour in the recovery room, all subjects in the four groups
were connected to a PCA system providing IV morphine
with boluses of 0.8mg in the subsequent 23 hours. There
was a lockout time of 8 minutes. Doses were registered on
a chart. Immediately on return to the general ward from the
recovery room, the subjects were asked to complete a VAS
for intensity of pain at the time. The VAS is a 10cm line
with extreme limits marked with perpendicular lines and4 Evidence-Based Complementary and Alternative Medicine
Table 5: Pain perceived by subjects over a 24-hour period using the visual analogue scale (in rank 0–10).
Gr. Time after operation (hours)
Zero Half One One-half Two Three Four Eight Sixteen Twenty-four
18 .04 ±2.65 7.27 ±2.34 6.77 ±2.29 5.81 ±2.19 5.58 ±2.13 6.00 ± 1.57 5.65 ±1.56 4.81 ±1.38 4.46 ± 1.38 3.50 ±1.27
27 .92 ±2.26 7.29 ±2.19 5.83 ±1.98 4.63 ±1.69 3.83 ±1.39 4.38 ± 1.61 4.17 ±1.70 3.54 ±1.54 3.04 ± 1.20 2.54 ±0.86
38 .59 ±1.71 6.95 ±2.65 6.45 ±2.78 6.05 ±3.03 5.48 ±3.02 4.73 ± 2.30 4.14 ±2.11 3.86 ±1.71 3.55 ± 1.67 2.68 ±1.63
47 .07 ±3.44 5.07 ±3.62 3.93 ±2.98 3.57 ±2.96 3.14 ±2.30 3.00 ± 2.27∧ 2.71 ±1.83∧ 2.57 ±1.41∧ 2.00 ± 1.75∧ 1.21 ±1.31∧
∧P<. 05.
Table 6: Dose of patient-controlled analgesia delivered (in mg).
Group Means over the four time intervals for PCA doses delivered
POR One–eight hours Eight–sixteen hours Sixteen–twenty four hours
14 .08 ±1.66 18.08 ±5.64 10.88 ±4.50 9.67 ±3.30
25 .17 ±2.98 17.73 ±3.52 8.28 ±2.50 7.55 ±2.37
34 .58 ±1.31 15.34 ±2.80 7.68 ±3.55 8.13 ±4.66
42 .30 ±2.00∧ 14.22 ±3.55 8.30 ±3.67 6.77 ±3.43
∧P<. 05.
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Figure 2: Pain perceived by subjects over a 24-hour period using
the visual analogue scale.
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Figure 3: PCA doses delivered in the postoperative room.
appropriate labels. Point zero on the line equals no pain,
and the other end point, 10cm away, equals maximum pain.
There areno words ornumbers at theendpoints. The subject
is requested to mark the line with an X reﬂecting their level
of pain by the appointed nurse. The main advantage of this
scale is that it can be viewed as a ratio scale with an inﬁnite
number of points on the line.
The time of the ﬁrst requirement of morphine, the
postoperative analgesic requirement (in the 24 hours), and
the number of PCA demands (i.e., button presses) in the
ﬁrst 24 hours were recorded. The subject’s age, weight, the
duration of anesthesia and surgery, ﬁrst requirement of
morphine, VAS scores, and PCA demands were analyzed
using one-way analysis of variance, comparing the diﬀer-
ence between groups of control, sham acupuncture, high-
frequency stimulation, and low-frequency stimulation.
3.Results
Forty-seven (47) subjects who had hysterectomies were
ﬁnally included in the study (Figure 1). The results were
analyzed using a one-way analysis of variance (ANOVA) for
VAS, PCA doses delivered, and PCA doses demanded by the
subjects. This method is for testing the diﬀerences between
the means of independent samples. In this case, using SPSS
and Student-Newman-Keuls (SNK) and Tukey post hoc
analysis performed a one-way ANOVA. F-tests were also
carried out to determine signiﬁcance between means of the
variables(M),timeofﬁrstambulationandbowelmovement,
t o t a lP C Ad e m a n d ,a n dt o t a lP C Ad o s e s .F distributions are
given with degree of freedom of 3 and 42 or 3 and 43.
3.1. SubjectsDescription. Forty-nine (49)consenting females
undergoing a hysterectomy were involved in the study. Two
ofthe subjectsfrom Group 4 were excludedfrom the analysis
due to the inability to carry out the VAS. The mean age
± standard deviation (SD) of the 47 subjects was 42.02 ±
8.31 years. The mean duration ± SD of the operation was
127.70 ± 34.56 minutes with an anesthetic time 166.04 ±
35.95 minutes (Table 2).
3.2. Postoperation General Recovering Conditions. Subjects’
related general recovering conditions, that is, time of ﬁrst
bowel movement, time of ﬁrst ambulation (when patientsEvidence-Based Complementary and Alternative Medicine 5
Table 7: Means of patient-controlled analgesia demanded by subjects of 24 hours postoperatively (in times of requests).
Group
Means of patient-controlled analgesia demanded by subjects of 24 hours postoperatively
POR One–eight hours Eight–sixteen
hours
Sixteen–twenty four
hours
11 5 .08 ± 11.34 49.54 ±34.61 22.08 ±14.03 12.92± 6.06
23 0 .83 ± 28.98 55.75 ±36.76 13.08 ±10.18 8.75 ±6.44
31 3 .00 ± 4.95 29.75 ±13.21 12.25 ±9.20 10.17 ±10.43
45 .90 ±4.32∧∧ 22.30 ±19.90∧ 11.80 ±12.41 7.50 ±5.37
∧P<. 05; ∧∧P<. 01.
Table 8: Total PCA demanded and delivered (in mg).
Group
Total PCA doses given for the four groups over 24-hour period postoperatively
Times delivered 24hr Times demand 24hr Dosage delivered 24hr
12 9 .16 ±11.79 84.54 ±38.66 38.63 ±11.08
23 1 .82 ±11.98 74.18 ±39.33 34.20 ±6.40
32 7 .75 ±11.78 52.17 ±21.87 31.14 ±8.15
42 3 .30 ±11.93 41.60 ±36.47 29.29 ±8.89∧
∧P<. 05.
felt they were capable of ambulating), and opioid-related
eﬀects after the operation were recorded, and comparisons
were made between groups using F-tests, with degree of
freedom of 3 and 42 or 3 and 43.
Table 3 shows the mean times (hours) and SD of the ﬁrst
bowel movement after the hysterectomy for subjects within
the four groups. Table 4 shows the mean times (hours) and
SD of ﬁrst ambulation after the hysterectomy for subjects
within the four groups. As can be seen in Tables 3 and 4,t h e
means and SD of the four groups are within a close range.
F-tests were performed on all means for each group for both
time of ﬁrst ambulation and time of ﬁrst bowel movement,
andnosigniﬁcantdiﬀerencesbetweenthemeanswerefound.
3.3. Visual Analogue Scale. The VAS was used to determine
the amount of perceived pain felt by subject (Table 5).
The data was collected over a 24-hour period commencing
postoperatively. A one-way ANOVA was used to test for
signiﬁcant diﬀerences between the groups at each speciﬁc
time interval. Figure 2 shows a clearly decreasing trend in the
amount of pain felt over the 24-hour period for all the four
groups with respect to the PCA and time.
Diﬀerences were found between the means at two hours
postoperatively, F(3,42) = 2.66, P<. 10; three hours post-
operatively, F(3,42) = 3.68, P<. 05; four hours postoper-
atively, F(3,42) = 4.33, P<. 05; eight hours postoperative-
ly, F(3,42) = 3.33, P<. 05; sixteen hours postoperatively,
F(3,42) = 4.25, P<. 05; twenty-four hours, F(3,42) = 4.67,
P<. 01. Further post hoc analysis showed that at one hour
postoperatively, Groups 1 and 4 were diﬀerent to each other
at the P<. 10 level. Also at three hours, Group 1 (M = 6.05)
was signiﬁcantly higher, at the P<. 05 level, than Group 4
(M = 3.00). This diﬀerence was also found at four hours,
Group 1 (M = 5.65) and Group 4 (M = 2.71); eight hours,
Group 1 (M = 4.81)and Group 4 (M = 2.57); sixteen hours,
Group 1 (M = 4.46) and Group 4 (M = 2.00); twenty-four
hours, Group1 (M = 3.50) and Group 4 (M = 1.21). M
corresponds to the mean values as given in Table 5.
Both post-hoc comparison tests indicate that Group 4
was signiﬁcantly diﬀerent from Groups 1, 2, and 3 at twenty-
four hours.
3.4. Patient-Controlled Analgesia Doses. Ao n e - w a yA N O V A
was applied to determine the diﬀerences between the means
over the four time intervals for PCA doses requirement
(Table 6).
Signiﬁcant diﬀerences were found, F(3,43) = 3.69, P<
.05, in the postoperative room (POR) between the groups.
Post-hoc analysis conﬁrmed and found that Group 4 (M =
2.30) was signiﬁcantly lower than Groups 2 (M = 5.17)
and 3 (M = 4.58). Post hoc comparison tests indicate that
mean PCA doses in the POR for Group 4 was signiﬁcantly
diﬀerent from Groups 2 and 3. Mean PCA doses between
Groups 1 and 4 showed no diﬀerences. These diﬀerences
are demonstrated in Table 6 and Figure 3.D i ﬀerences were
also found between the groups between one and eight hours
postoperatively, F(3,43) = 2.33, P<. 10. However, post hoc
analysis did not conﬁrm this ﬁnding between any of the four
groups.
3.5. Patient-Controlled Analgesia Doses Demanded. Table 7
shows that the four groups have a similar trend within 24
hours postoperatively. However, signiﬁcant diﬀerences were
found between the means at the POR, F(3,43) = 4.80, P<
.01, and one to eight hours postoperatively, F(3,43) = 3.49,
P<. 05.Posthocanalysisconﬁrmedthesigniﬁcant diﬀerence
between the means at one to eight hours postoperatively that
Group 2 (M = 55.75) was signiﬁcantly higher than Group 4
(M = 22.30).
Post hoc analysis also conﬁrmed that Group 2 (M =
30.83) was signiﬁcantly higher than Group 3 (M = 13.00)
and Group 4 (M = 5.90) at the POR. No other signiﬁcance
was found between means.
3.6. Total Patient-Controlled Analgesia Doses and Demands.
As demonstrated in Table 8,t h e r ew a sn os i g n i ﬁ c a n td i f -
ference between the total PCA doses times given for the6 Evidence-Based Complementary and Alternative Medicine
four groups over 24-hour period postoperatively. However,
a one way ANOVA was applied to compare the groups for
total PCA doses demanded, and signiﬁcant diﬀerences were
found between the groups F(3,42) = 3.59, P<. 05. Post
hoc analysis conﬁrmed the diﬀerence between Groups 1
(M = 84.54) and 4 (M = 41.60). Moreover, diﬀerences were
found between the four groups for the amount of analgesia
delivered in mg, F(3,43) = 2.45, P<. 10. Post-hoc analysis
conﬁrmed this ﬁnding between Groups 1 (M = 38.63) and 4
(M = 29.29).
4.Discussion
4.1. Subject Number. In this study the initial plan was to
recruit 60 subjects as a clinical trial; however, 49 subjects
enrolled in this study and achieved signiﬁcant outcomes
in several measurements. Other studies which produced
signiﬁcant results show that subject numbers vary in many
pain management projects using acupuncture, EA or SSP.
Kurokawa [3] reported that a clinical trial involving 30
subjects (10 in each group) showed positive outcomes of
using SSP.Ishimaru etal.[4]indicatedthatsigniﬁcant results
were gained by using EA in 16 subjects.
4.2. Postoperation General Conditions. The point ST36 is
expected to regulate bowel movement, relieve abdominal
pain, and improve energy [5] and, therefore, improve
the time of subject’s ﬁrst bowel movement and time of
ﬁrst ambulation and reduce opioid-related eﬀects after the
surgery. The fact that there was no signiﬁcant diﬀerence
between the groups with regard to ﬁrst bowel movement
time and ﬁrst ambulation time is a point which awaits to be
studied.
4.3. Total PCA Demand and Doses. A similar study con-
ducted by Lin [6], explored the eﬀects of high- and low-
frequency electroacupuncture in pain after lower abdominal
surgery. The results showed that the ﬁrst time of analgesic
request was 10, 18, 28, and 28 minutes in the control, sham-,
low-, and high-EA groups, respectively. In addition, during
the ﬁrst 24 hours 21, 43, and 61% in the sham-, low-, and
high-EA groups decreased the total amount of morphine
required, respectively.
In this study, the results showed that the PCA doses
deliveredinthepostoperativeroomwere4.08,5.17,4.58,and
2.30mg in the control, sham-, high-, and low-EA groups,
respectively. However, the total amount of dose delivery
during the ﬁrst 24 hours decreased to 53, 43, 53, and 48% in
the control, sham-, high-, and low-EA groups, respectively.
4.4. Pain Intensity. The results of this study showed that
there were signiﬁcantly lower mean pain scores in the
treatment groups compared with the control group. Pain
assessment, for the ﬁrst two hours, was every half an hour,
andsubsequentlyatthe3rd,4th,8th,16th,and24thhoursby
VAS. All groups had high mean pain scores at zero hour. In
Groups 1 and 4, the diﬀerence was signiﬁcant at the 1st, 3rd,
and 4th hours. However, in Groups 1 and 3, the signiﬁcant
diﬀerence was shown at the 2nd hour and parallel to the
24th hour. It seems that SSP needle-free EA can help with
postoperative pain management. While the positive pain-
reducing eﬀects are evident within the measured time frame,
further investigations involving the long-term treatment
eﬀects may be worthy of future study.
The positive pain-relieving results found in this study
could be supported by the theory that endorphins may be
produced by both SSP electrode stimulation and acupunc-
ture. Alternatively when Naloxone, an antinarcotic sub-
stance, is administered, it is found to reverse the analgesic
eﬀe c to fe n d o r p h i n sa si ti sa b l et oc o m b i n ew i t hm o r p h i n e
receptors stronger than endorphins [7]. The results of the
study may be interpreted that low-frequency surface point
stimulation such as SSP is also related to endorphin release
in the body.
5.Conclusion
Silver spike point needle-free electroacupuncture has shown
to have positive eﬀects for postoperative pain management.
The ﬁndings of this study are important for those patients
who seek nonpharmacological analgesia without side eﬀects.
Although further study is needed to ultimately determine
whether SSPneedle-free EA has a place inpostoperative pain
treatment, this study shows that SSP needle-free EA may be
able to make a contribution as an adjunct to other forms of
medical intervention. Arguably this “needle-free approach”
has beneﬁts forpatientswho havediﬃcultieswith traditional
acupuncture needling and at the same time are interested in
a nonpharmacological approach to treat pain.
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